Abstract
Background Delineation of Parkinson’s disease (PD) from multiple system atrophy (MSA) can be challenging, especially in early disease stages, and clinical markers are needed for early detection of MSA. Speech characteristics have been studied as digital biomarkers in PD and ataxias, but there is only little data on MSA.
Objectives To determine whether speech characteristics can serve as a biomarker to differentiate between MSA and PD.
Methods 21 MSA patients and 23 PD patients underwent a battery of speech task assessments: text reading, sustained phonation and diadochokinetic tasks. Speech characteristics were extracted using the software Praat.
Results MSA and PD speech can be described by the factors: “time and pauses”, “harsh voice”, and a factor containing “mixed speech characteristics”. After correcting for MDS-UPDRS III, four parameters and the “time and pause” factor showed significant differences between MSA and PD. MSA could be delineated from PD with Receiver Operator Characteristic Area Under the Curve (ROC-AUC) of 0.89 by a single speech parameter together with MDS-UPDRS III.
Conclusion MSA can be differentiated from PD with good accuracy using only MDS-UPDRS III and one speech parameter as predictors. This outlines the importance of speech assessments to delineate MSA from PD to allow for differential diagnosis in movement disorders.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study did not receive any funding.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Institutional review board of Technische Universitaet Dresden, Germany gave ethical approval for this work Institutional review board of Brandenburg State Medical Association gave ethical approval for this work
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Footnotes
Financial Disclosure/Conflict of Interest: All authors declare no financial or non-financial conflict of interest.
No funding was obtained for conducting this study.
Data Availability
All Praat scripts used for our analyses are available at github.com/t-haehnel/MSA-Speech-Analysis-Praat. Speech recordings can not be made available to others due to privacy reasons.
